Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Galaxy Brain Scientific is a neurotechnology company specializing in the development of digital therapeutics for neurorehabilitation and brain health. Founded by neuroscientists from Johns Hopkins University, the company developed the KATA platform, which utilizes immersive, motion-based gaming environments to promote neuroplasticity and motor recovery. Their approach focuses on delivering high-dose, high-intensity training through engaging software to improve outcomes for patients with stroke, traumatic brain injury, and other neurological conditions. The company's technology is designed to bridge the gap between clinical research in motor learning and practical, scalable rehabilitation solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Galaxy Brain Scientific.